Larisa Alekseevna Chegus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Larisa Alekseevna Chegus has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Alina V. Solovyeva
RUDN University
13 shared publications - Ekaterina Yu. Aleynikova
Peoples’ Friendship University of Russia named after Patrice Lumumba
7 shared publications - Anzhelika Eduardovna Kasparova
Khanty-Mansiysk State Medical Academy, Khanty-Mansiysk, Russia
4 shared publications Khanty-Mansiysk State Medical Academy
4 shared publicationsЕ. Ю. Алейникова
Российский университет дружбы народов имени Патриса Лумумбы
4 shared publications- K. S. Ermolenko
Peoples’ Friendship University of Russia
3 shared publications
Latest Publications
- Open Access
- 7 November 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 17,p. 47-51
Iron deficiency anemia and anemia of chronic disease – what is known?
Anemia is the most common disease in the world, affecting about 30–40% of people. Children, adolescents, and women are most often affected by anemia. The main causes of true iron deficiency (ID and IDA) are insufficient iron intake, increased iron loss (chronic bleeding), increased iron requirement, and impaired iron absorption (gastrointestinal diseases). Chronic diseases, inflammatory conditions, autoimmune diseases, obesity cause an increase in the synthesis of hepcidin in the liver and block the entry of iron into the bloodstream, leading to functional iron deficiency. Anemia of chronic diseases (ACD) or anemia of chronic inflammation (the second most common anemia) is associated with the fact that iron is present in the body, but the absorption of iron in various areas is limited. Until recently, it was believed that treatment with iron supplements in the absence of iron deficiency does not bring benefit to patients with ACD. The opinion has been repeatedly expressed about the harm of iron therapy, since iron is necessary for the growth of some pathogenic microorganisms and tumor cells. However, the real clinical significance of these mainly theoretical provisions is unknown. Therefore, the prescription of iron preparations for anemia is justified and logical. Ferrous sulfate (ferrous iron) is most often prescribed orally due to its low cost, high bioavailability and effectiveness. The drug Tardiferon, containing iron sulphate 247.25 mg (in terms of iron (II) 80.00 mg), is widely used in patients with IDA and ID, since divalent iron has a high ability to overcome the intestinal barrier by “passive” transport and quickly create high concentrations in the blood, restoring the level of hemoglobin and iron stores in the body. The drug Tardiferon has a relatively low dose of iron – 80 mg with slow-release technology to avoid irritating effects on the intestine, contributing to good tolerability. A number of studies confirmed a high safety profile – patients did not refuse to take the drug due to side effects. Timely examination and identification of patients with anemia allows you to prescribe an effective correction. The drug Tardiferon promotes rapid restoration of hemoglobin and iron stores in the body and has good tolerability.
- 7 November 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 17,p. 47-51
Open AccessIron deficiency anemia and anemia of chronic disease – what is known?
Anemia is the most common disease in the world, affecting about 30–40% of people. Children, adolescents, and women are most often affected by anemia. The main causes of true iron deficiency (ID and IDA) are insufficient iron intake, increased iron loss (chronic bleeding), increased iron requirement, and impaired iron absorption (gastrointestinal diseases). Chronic diseases, inflammatory conditions, autoimmune diseases, obesity cause an increase in the synthesis of hepcidin in the liver and block the entry of iron into the bloodstream, leading to functional iron deficiency. Anemia of chronic diseases (ACD) or anemia of chronic inflammation (the second most common anemia) is associated with the fact that iron is present in the body, but the absorption of iron in various areas is limited. Until recently, it was believed that treatment with iron supplements in the absence of iron deficiency does not bring benefit to patients with ACD. The opinion has been repeatedly expressed about the harm of iron therapy, since iron is necessary for the growth of some pathogenic microorganisms and tumor cells. However, the real clinical significance of these mainly theoretical provisions is unknown. Therefore, the prescription of iron preparations for anemia is justified and logical. Ferrous sulfate (ferrous iron) is most often prescribed orally due to its low cost, high bioavailability and effectiveness. The drug Tardiferon, containing iron sulphate 247.25 mg (in terms of iron (II) 80.00 mg), is widely used in patients with IDA and ID, since divalent iron has a high ability to overcome the intestinal barrier by “passive” transport and quickly create high concentrations in the blood, restoring the level of hemoglobin and iron stores in the body. The drug Tardiferon has a relatively low dose of iron – 80 mg with slow-release technology to avoid irritating effects on the intestine, contributing to good tolerability. A number of studies confirmed a high safety profile – patients did not refuse to take the drug due to side effects. Timely examination and identification of patients with anemia allows you to prescribe an effective correction. The drug Tardiferon promotes rapid restoration of hemoglobin and iron stores in the body and has good tolerability.
- Open Access
- 9 May 2024
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 26 (1) , 76-82
Uterine artery embolization in the treatment of uterine fibroids and the preservation of reproductive health in women 40 years of age and older: A retrospective study
Aim. To evaluate the effect of uterine artery embolization (UAE) on reproductive health in women 40 years and older. Materials and methods. A retrospective study was conducted at the perinatal center of the District Clinical Hospital of Khanty-Mansiysk. Patients were divided into two groups: the main group (group 1; n=57) included women with uterine fibroids after UAE, and the control group (group 2; n=42) included women without a history of uterine fibroids. Results. Women with uterine fibroids were statistically more likely to have grade 1 obesity (χ2=4.39; p=0.04) and less likely to have normal body weight (χ2=8.73; p=0.00) compared to women without fibroids. Smoking increased the risk of uterine fibroids twofold (χ2=4.49; p=0.03; odds ratio 1.97; confidence interval 0.64-6.11). More women with uterine fibroids had a history of abortions (n=42; 73.7%) than those without uterine fibroids (n=19; 45.2%; χ2=8.27; p=0.01). The most common gynecological comorbidities in women with uterine fibroids included inflammatory disease of the uterus (N71), endometrial polyp (N84), and endometriosis (N80); p0.05. The most common extragenital diseases in patients with uterine fibroids included thyroid disease, hypertension, and iron deficiency anemia (p0.05). Contour SE embolization agent with spherical particles was more often associated with pain (χ2=0.18; p=0.67) and less often with fever (χ2=4.47; p=0.03). There was a decrease in the number of short menstrual cycles (less than 24 days) from the moment before surgical treatment and after 24 months (χ2=34.580; p0.001) and an increase in the number of cycles of 24–38 days (χ2=14.887; p=0.005). At 24 months after UAE, there were more women with a menstrual period of less than 3 days (χ2=10.385; p=0.035) and fewer with a menstrual period of more than 8 days (χ2=34.573; p0.001). Ultrasound showed a decreased ovarian reserve at 6, 12 and 24 months after UAE (p0.05). Conclusion. When assessing the reproductive health of women 40 years and older after embolization of the uterine arteries, it was found that this method of treatment of symptomatic uterine fibroids leads to a decrease in the duration and heaviness of menstruation but increases the risk of an ovarian reserve decrease.
- 9 May 2024
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 26 (1) , 76-82
Open AccessUterine artery embolization in the treatment of uterine fibroids and the preservation of reproductive health in women 40 years of age and older: A retrospective study
Aim. To evaluate the effect of uterine artery embolization (UAE) on reproductive health in women 40 years and older. Materials and methods. A retrospective study was conducted at the perinatal center of the District Clinical Hospital of Khanty-Mansiysk. Patients were divided into two groups: the main group (group 1; n=57) included women with uterine fibroids after UAE, and the control group (group 2; n=42) included women without a history of uterine fibroids. Results. Women with uterine fibroids were statistically more likely to have grade 1 obesity (χ2=4.39; p=0.04) and less likely to have normal body weight (χ2=8.73; p=0.00) compared to women without fibroids. Smoking increased the risk of uterine fibroids twofold (χ2=4.49; p=0.03; odds ratio 1.97; confidence interval 0.64-6.11). More women with uterine fibroids had a history of abortions (n=42; 73.7%) than those without uterine fibroids (n=19; 45.2%; χ2=8.27; p=0.01). The most common gynecological comorbidities in women with uterine fibroids included inflammatory disease of the uterus (N71), endometrial polyp (N84), and endometriosis (N80); p0.05. The most common extragenital diseases in patients with uterine fibroids included thyroid disease, hypertension, and iron deficiency anemia (p0.05). Contour SE embolization agent with spherical particles was more often associated with pain (χ2=0.18; p=0.67) and less often with fever (χ2=4.47; p=0.03). There was a decrease in the number of short menstrual cycles (less than 24 days) from the moment before surgical treatment and after 24 months (χ2=34.580; p0.001) and an increase in the number of cycles of 24–38 days (χ2=14.887; p=0.005). At 24 months after UAE, there were more women with a menstrual period of less than 3 days (χ2=10.385; p=0.035) and fewer with a menstrual period of more than 8 days (χ2=34.573; p0.001). Ultrasound showed a decreased ovarian reserve at 6, 12 and 24 months after UAE (p0.05). Conclusion. When assessing the reproductive health of women 40 years and older after embolization of the uterine arteries, it was found that this method of treatment of symptomatic uterine fibroids leads to a decrease in the duration and heaviness of menstruation but increases the risk of an ovarian reserve decrease.
- Open Access
- 2 May 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 4,p. 119-125
Pregravid preparation for women with bacterial vaginosis and a history of early pregnancy loss
Introduction. Statistics show that about 13 to 15 in 100 pregnancies end in early miscarriage. This represents both a medical and social issue, as such outcome may be associated with maternal depression and anxiety, which inevitably affects women’s activities, performance efficiency and social inclusion. Restoration of normobiocenosis and lactobacilli pool dominance is one of the key challenges for women planning pregnancy.Aim. To evaluate the effectiveness of probiotics at the pregravid preparation stage in women with a history of early pregnancy loss and bacterial vaginosis (BV).Materials and methods. We selected 46 patients of reproductive age (24–39 years) who applied for early pregnancy loss, with complaints of vaginal discharge with an unpleasant odour, pruritus, burning, and dyspareunia, using databases of 5 medical clinics in Moscow, Tyumen and Stavropol. To treat bacterial vaginosis, two-stage therapy aimed at eliminating the increased number of anaerobic microorganisms and restoring the vaginal microbiocenosis was used.Results. The effectiveness of combination therapy was assessed at 1 month. All patients on therapy experienced clinical improvement, normalization of vaginal microbiocenosis parameters based on Femoflor-16 test findings after the end of treatment. Physiological microbiocenosis of Lactobacillus spp. > 107 was detected in 43 (94.5%). In all patients, the average vaginal pH after two-stage therapy was 4.3 ± 0.7. The safety of Acilact Duo therapy was assessed in all study participants. No negative trends were recorded.Conclusion. Superlimflife (Acilact Duo), acidophilus bacteria + vitamin-mineral protein-peptide complex, quickly restores optimal vaginal acidity (pH), stimulates the growth of lactobacilli, and reduces the incidence of BV relapses.
- 2 May 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 4,p. 119-125
Open AccessPregravid preparation for women with bacterial vaginosis and a history of early pregnancy loss
Introduction. Statistics show that about 13 to 15 in 100 pregnancies end in early miscarriage. This represents both a medical and social issue, as such outcome may be associated with maternal depression and anxiety, which inevitably affects women’s activities, performance efficiency and social inclusion. Restoration of normobiocenosis and lactobacilli pool dominance is one of the key challenges for women planning pregnancy.Aim. To evaluate the effectiveness of probiotics at the pregravid preparation stage in women with a history of early pregnancy loss and bacterial vaginosis (BV).Materials and methods. We selected 46 patients of reproductive age (24–39 years) who applied for early pregnancy loss, with complaints of vaginal discharge with an unpleasant odour, pruritus, burning, and dyspareunia, using databases of 5 medical clinics in Moscow, Tyumen and Stavropol. To treat bacterial vaginosis, two-stage therapy aimed at eliminating the increased number of anaerobic microorganisms and restoring the vaginal microbiocenosis was used.Results. The effectiveness of combination therapy was assessed at 1 month. All patients on therapy experienced clinical improvement, normalization of vaginal microbiocenosis parameters based on Femoflor-16 test findings after the end of treatment. Physiological microbiocenosis of Lactobacillus spp. > 107 was detected in 43 (94.5%). In all patients, the average vaginal pH after two-stage therapy was 4.3 ± 0.7. The safety of Acilact Duo therapy was assessed in all study participants. No negative trends were recorded.Conclusion. Superlimflife (Acilact Duo), acidophilus bacteria + vitamin-mineral protein-peptide complex, quickly restores optimal vaginal acidity (pH), stimulates the growth of lactobacilli, and reduces the incidence of BV relapses.
- Open Access
- 1 May 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 4,p. 48-55
Courses of pregnancy in women witha uterine scar after conservative myomectomy
Introduction. Uterine fibroids are the most common disease of the female reproductive system. If indicated, the main organpreserving method of treatment is myomectomy. However, according to many researchers, women who have undergone conservative myomectomy are at a higher risk of developing complications during pregnancy such as placenta previa, placental disorders, and uterine scar failure.Aim. To identify the features of the course of pregnancy, childbirth and perinatal outcome in women with a uterine scar after conservative myomectomy who received pregravid preparation.Materials and methods. A retrospective study included an analysis of 159 outpatient histories of women planning pregnancy after conservative myomectomy, including the birth histories of 109 pregnant women aged 29–40 years who delivered at the Perinatal Center of the Regional Clinical Hospital in Khanty-Mansiysk from 2011 to 2021 in order to study the characteristics of the course of pregnancy in women with a scar on the uterus after conservative myomectomy.Results. When analyzing the data, the following statistically significant differences between the groups were revealed: the first trimester of pregnancy in women with a uterine scar compared with the control group was more often complicated by chorion presentation, threatened miscarriage, urinary tract infection and early toxicosis (p < 0.05); in the second trimester of pregnancy in group 1, there were more often threatening preterm labor and placental disorders (p < 0.05), the majority of women with a scar on the uterus after myomectomy (77.8%) were delivered by caesarean section, in contrast to the control group (9.7%) (p < 0.05).Conclusion. The data we obtained on the course of pregnancy, childbirth and perinatal outcomes after myomectomy reflected the need and effectiveness of preconception preparation in this contingent of women.
- 1 May 2024
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 4,p. 48-55
Open AccessCourses of pregnancy in women witha uterine scar after conservative myomectomy
Introduction. Uterine fibroids are the most common disease of the female reproductive system. If indicated, the main organpreserving method of treatment is myomectomy. However, according to many researchers, women who have undergone conservative myomectomy are at a higher risk of developing complications during pregnancy such as placenta previa, placental disorders, and uterine scar failure.Aim. To identify the features of the course of pregnancy, childbirth and perinatal outcome in women with a uterine scar after conservative myomectomy who received pregravid preparation.Materials and methods. A retrospective study included an analysis of 159 outpatient histories of women planning pregnancy after conservative myomectomy, including the birth histories of 109 pregnant women aged 29–40 years who delivered at the Perinatal Center of the Regional Clinical Hospital in Khanty-Mansiysk from 2011 to 2021 in order to study the characteristics of the course of pregnancy in women with a scar on the uterus after conservative myomectomy.Results. When analyzing the data, the following statistically significant differences between the groups were revealed: the first trimester of pregnancy in women with a uterine scar compared with the control group was more often complicated by chorion presentation, threatened miscarriage, urinary tract infection and early toxicosis (p < 0.05); in the second trimester of pregnancy in group 1, there were more often threatening preterm labor and placental disorders (p < 0.05), the majority of women with a scar on the uterus after myomectomy (77.8%) were delivered by caesarean section, in contrast to the control group (9.7%) (p < 0.05).Conclusion. The data we obtained on the course of pregnancy, childbirth and perinatal outcomes after myomectomy reflected the need and effectiveness of preconception preparation in this contingent of women.
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 12 (1)
Effectiveness of prevention and early diagnosis of critical obstetric conditions in preeclampsia as a factor in reducing maternal and infant morbidity and mortality
Эффективность профилактики и ранней диагностики критических акушерских состояний при преэклампсии как фактора снижения материнской и младенческой
- 1 January 2024
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 12 (1)
Open AccessEffectiveness of prevention and early diagnosis of critical obstetric conditions in preeclampsia as a factor in reducing maternal and infant morbidity and mortality
Эффективность профилактики и ранней диагностики критических акушерских состояний при преэклампсии как фактора снижения материнской и младенческой
- 1 January 2024
- Published by NP Rusmedical Group in Women's Health and Reproduction
- Vol. 61 (1)
Health status and subjective assessment of quality of life in women before surgical treatment (myomectomy)
Aim. To evaluate the health status and quality of life of women before surgical treatment (myomectomy). Design. Cross-sectional study. Materials and methods. The study was conducted in 2022–2023 at the clinical sites of the Department of Obstetrics and Gynecology with a course of perinatology at the Medical Institute of the RUDN University in the State Clinical Hospital named after. V.M. Buyanova, gynecological department and antenatal clinic No. 5 of the State Budgetary Healthcare Institution City Clinical Hospital No. 1 named after. N.I. Pirogov. Based on an analysis of medical records using a continuous sampling method, 90 women of reproductive age (15–49 years according to the World Health Organization classification) with uterine fibroids were included in the study. An analysis of complaints, general and obstetric-gynecological anamnesis, clinical, laboratory and instrumental examinations of patients was carried out, and women were questioned using the UFS-QOL questionnaire. Results. The average age of the studied patients was 41.4 years. 44 (48.9%) women had heavy menstruation. In the structure of extragenital diseases, the most common history cases were iron deficiency anemia — 42 (46.7%) cases, hypertension — 9 (10%) and obesity — 12 (13.3%), and among gynecological diseases, abnormal uterine bleeding prevailed — in 39 (43.3%) patients. Analysis of clinical blood test data showed that 11 (12.2%) women had moderate anemia, and 39 (43.3%) had mild anemia. A decrease in hemoglobin level was accompanied by the presence of microcytosis (MCV — 76.5 ± 4.2 pg) and hypochromia (MCH — 24.8 ± 4.2 pg). Complaints of weakness, decreased ability to work and endurance were detected in 43 (47.8%) patients with anemia, 8 (8.9%) women noted dizziness, and 2 (2.2%) had episodes of chest discomfort and rapid heartbeat . It was noted that, according to the UFS-QOL questionnaire, all patients determined the severity of symptoms of uterine fibroids as moderate (43.02 ± 18.39 points) with fairly low indicators of all quality of life parameters in most women: in 31 (34.4%) women the score did not exceed 50 points, which can be regarded as low quality of life, 38 (42.2%) had no more than 75 points — moderately reduced. Analysis of data from women with uterine fibroids according to the odds ratio theory revealed the following patterns: when the size of the myomatous node is 40 mm or more, the chance of heavy menstruation statistically significantly increased (odds ratio (OR) = 6.333, 95% confidence interval (CI) — 1.884–15.025, p 0.05). Conclusion. Reduced quality of life, increased levels of anxiety, sexual dysfunction, heavy menstruation associated with uterine fibroids determine the need for early diagnosis and comprehensive treatment of such patients. Key words: uterine fibroids, abnormal uterine bleeding, iron deficiency anemia.
- 1 January 2024
- Published by NP Rusmedical Group in Women's Health and Reproduction
- Vol. 61 (1)
Health status and subjective assessment of quality of life in women before surgical treatment (myomectomy)
Aim. To evaluate the health status and quality of life of women before surgical treatment (myomectomy). Design. Cross-sectional study. Materials and methods. The study was conducted in 2022–2023 at the clinical sites of the Department of Obstetrics and Gynecology with a course of perinatology at the Medical Institute of the RUDN University in the State Clinical Hospital named after. V.M. Buyanova, gynecological department and antenatal clinic No. 5 of the State Budgetary Healthcare Institution City Clinical Hospital No. 1 named after. N.I. Pirogov. Based on an analysis of medical records using a continuous sampling method, 90 women of reproductive age (15–49 years according to the World Health Organization classification) with uterine fibroids were included in the study. An analysis of complaints, general and obstetric-gynecological anamnesis, clinical, laboratory and instrumental examinations of patients was carried out, and women were questioned using the UFS-QOL questionnaire. Results. The average age of the studied patients was 41.4 years. 44 (48.9%) women had heavy menstruation. In the structure of extragenital diseases, the most common history cases were iron deficiency anemia — 42 (46.7%) cases, hypertension — 9 (10%) and obesity — 12 (13.3%), and among gynecological diseases, abnormal uterine bleeding prevailed — in 39 (43.3%) patients. Analysis of clinical blood test data showed that 11 (12.2%) women had moderate anemia, and 39 (43.3%) had mild anemia. A decrease in hemoglobin level was accompanied by the presence of microcytosis (MCV — 76.5 ± 4.2 pg) and hypochromia (MCH — 24.8 ± 4.2 pg). Complaints of weakness, decreased ability to work and endurance were detected in 43 (47.8%) patients with anemia, 8 (8.9%) women noted dizziness, and 2 (2.2%) had episodes of chest discomfort and rapid heartbeat . It was noted that, according to the UFS-QOL questionnaire, all patients determined the severity of symptoms of uterine fibroids as moderate (43.02 ± 18.39 points) with fairly low indicators of all quality of life parameters in most women: in 31 (34.4%) women the score did not exceed 50 points, which can be regarded as low quality of life, 38 (42.2%) had no more than 75 points — moderately reduced. Analysis of data from women with uterine fibroids according to the odds ratio theory revealed the following patterns: when the size of the myomatous node is 40 mm or more, the chance of heavy menstruation statistically significantly increased (odds ratio (OR) = 6.333, 95% confidence interval (CI) — 1.884–15.025, p 0.05). Conclusion. Reduced quality of life, increased levels of anxiety, sexual dysfunction, heavy menstruation associated with uterine fibroids determine the need for early diagnosis and comprehensive treatment of such patients. Key words: uterine fibroids, abnormal uterine bleeding, iron deficiency anemia.
- Open Access
- 21 October 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 15,p. 53-56
Replenishment of iron deficiency in women before the use of assisted reproductive technologies
Introduction. Anemia is a major health problem worldwide, increasing the risks of low birth weight, preterm birth, perinatal mortality, stillbirth, postpartum hemorrhage, and maternal mortality. Replenishing iron deficiency at the stage of preconceptional preparation reduces the incidence of IDA and can reduce the incidence of pregnancy complications and improve perinatal outcomes.Aim. To evaluate the effectiveness of ferrous sulfate 80 mg and its potential to replenish iron deficiency in women with infertility before using assisted reproductive technologies (ART).Materials and methods. A prospective clinical longitudinal study was conducted from May to September 2023 at LLC Health Clinic, Moscow. The study included women (n = 34) at the stage of pregnancy planning by IVF with a diagnosed iron deficiency. Iron deficiency was established in accordance with the following criteria: decrease in serum ferritin level less than 30 μg/l, serum iron level less than 15 μmol/l.Results. After 12 weeks of taking ferrous sulfate, the average hemoglobin level increased from 112.3 ± 6.5 (101–119) g/l to 118.5 ± 6.5 (110–133) g/l (W-Wilcoxon 9300 test, p = 0.003), mean serum iron level from 15.4 ± 4.0 (5.7–22.5) μmol/l to 34.8 ± 7.1 (20.1–46.7) μmol/l (Wilcoxon W test 602.0, p < 0.001), mean ferritin level from 8.2 ± 3.1 (4.5–17.0) μg/ml to 37.6 ± 6.7 (30.6–52.6) μg/ml (Wilcoxon W test 595.0, p < 0.001).Conclusions. Timely examination of patients for iron deficiency and iron deficiency anemia at the stage of preconceptional preparation makes it possible to prescribe an effective correction, thereby helping to reduce the risks of complications of pregnancy and childbirth.
- 21 October 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 15,p. 53-56
Open AccessReplenishment of iron deficiency in women before the use of assisted reproductive technologies
Introduction. Anemia is a major health problem worldwide, increasing the risks of low birth weight, preterm birth, perinatal mortality, stillbirth, postpartum hemorrhage, and maternal mortality. Replenishing iron deficiency at the stage of preconceptional preparation reduces the incidence of IDA and can reduce the incidence of pregnancy complications and improve perinatal outcomes.Aim. To evaluate the effectiveness of ferrous sulfate 80 mg and its potential to replenish iron deficiency in women with infertility before using assisted reproductive technologies (ART).Materials and methods. A prospective clinical longitudinal study was conducted from May to September 2023 at LLC Health Clinic, Moscow. The study included women (n = 34) at the stage of pregnancy planning by IVF with a diagnosed iron deficiency. Iron deficiency was established in accordance with the following criteria: decrease in serum ferritin level less than 30 μg/l, serum iron level less than 15 μmol/l.Results. After 12 weeks of taking ferrous sulfate, the average hemoglobin level increased from 112.3 ± 6.5 (101–119) g/l to 118.5 ± 6.5 (110–133) g/l (W-Wilcoxon 9300 test, p = 0.003), mean serum iron level from 15.4 ± 4.0 (5.7–22.5) μmol/l to 34.8 ± 7.1 (20.1–46.7) μmol/l (Wilcoxon W test 602.0, p < 0.001), mean ferritin level from 8.2 ± 3.1 (4.5–17.0) μg/ml to 37.6 ± 6.7 (30.6–52.6) μg/ml (Wilcoxon W test 595.0, p < 0.001).Conclusions. Timely examination of patients for iron deficiency and iron deficiency anemia at the stage of preconceptional preparation makes it possible to prescribe an effective correction, thereby helping to reduce the risks of complications of pregnancy and childbirth.
- Open Access
- 9 July 2023
- Published by VSMU N.N. Burdenko in Journal of Anatomy and Histopathology
- Vol. 12 (2) , 99-105
An uncommon case of placental histopathology with antenatal fetal death under new coronavirus infection
Since the beginning of the COVID-19 pandemic, there have been a number of studies related to the impact of SARS-CoV-2 on the course of pregnancy and fetus condition. As observed, the placentas of women who have had a new coronavirus infection often contain more villous agglutination and subchorionic thrombi than placentas in SARS-CoV-2-negative women. To date, several isolated publications have reported clinical cases of fetal death in mothers infected with coronavirus infection. The authors have made an assumption on the association of adverse outcomes with placental lesions. The aim of the study was to analyse a clinical case of a moderate-course new coronavirus infection in a pregnant woman at a long gestation period who underwent an antenatal fetal death, and evaluate the features of placental histopathology and their impact on adverse gestational outcomes. Material and methods. The authors have analysed Russian and international research publications from various sources, including eLIBRARY.RU, CyberLeninka, PubMed databases etc. and, considering the data obtained, investigated a clinical case of intrauterine fetal death in a pregnant woman infected with SARS-CoV-2. The placenta was studied in accordance with the clinical recommendations of the Russian Society of Pathologists "Rules for placental pathological and anatomical examination" and the international classification of placental lesions (Amsterdam, 2015). Results. The results obtained support the association between acute diseases of the upper respiratory tract and developing severe hemodynamic disorders in the "mother-placenta-fetus" system in pregnant women infected with SARS-CoV-2. Systemic inflammation associated with new coronavirus infection appears to be one of the mechanisms for developing placental disorders.
- 9 July 2023
- Published by VSMU N.N. Burdenko in Journal of Anatomy and Histopathology
- Vol. 12 (2) , 99-105
Open AccessAn uncommon case of placental histopathology with antenatal fetal death under new coronavirus infection
Since the beginning of the COVID-19 pandemic, there have been a number of studies related to the impact of SARS-CoV-2 on the course of pregnancy and fetus condition. As observed, the placentas of women who have had a new coronavirus infection often contain more villous agglutination and subchorionic thrombi than placentas in SARS-CoV-2-negative women. To date, several isolated publications have reported clinical cases of fetal death in mothers infected with coronavirus infection. The authors have made an assumption on the association of adverse outcomes with placental lesions. The aim of the study was to analyse a clinical case of a moderate-course new coronavirus infection in a pregnant woman at a long gestation period who underwent an antenatal fetal death, and evaluate the features of placental histopathology and their impact on adverse gestational outcomes. Material and methods. The authors have analysed Russian and international research publications from various sources, including eLIBRARY.RU, CyberLeninka, PubMed databases etc. and, considering the data obtained, investigated a clinical case of intrauterine fetal death in a pregnant woman infected with SARS-CoV-2. The placenta was studied in accordance with the clinical recommendations of the Russian Society of Pathologists "Rules for placental pathological and anatomical examination" and the international classification of placental lesions (Amsterdam, 2015). Results. The results obtained support the association between acute diseases of the upper respiratory tract and developing severe hemodynamic disorders in the "mother-placenta-fetus" system in pregnant women infected with SARS-CoV-2. Systemic inflammation associated with new coronavirus infection appears to be one of the mechanisms for developing placental disorders.
- Open Access
- 20 January 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 23,p. 224-230
Effectiveness of endometrial scratching in infertility treatment with assisted reproductive technologies
Embryo implantation is a key factor limiting the effectiveness of assisted reproductive technologies, and depends on the quality of the blastocyst and the susceptibility of the endometrium. Various methods of treatment aimed at improving the receptivity of the uterine mucosa, including endometrial scratching, have been proposed. At the same time, the main mechanisms underlying this intervention remain unclear. Moreover, the optimal duration of exposure to the uterine mucosa and the groups of patients in which it can have a positive effect have not been determined. The study aims to investigate the main mechanisms and evaluate the effectiveness of local endometrial damage performed at various times before embryo transfer in the program of assisted reproductive technologies in women with and without a history of implantation failures based on the analysis of scientific literature. Clinical studies, systematic reviews and meta-analyses were studied in PubMed, Embase, Cochrane Library, Web of Science databases, Elsevier, Springer, Wiley publishers, on eLibrary, Research Gate platforms, in open sources of the scientific and educational segment of the Internet. The literature search was conducted by keywords: endometrial scratching, local endometrial damage, implantation failures, endometrial receptivity, assisted reproductive technologies, infertility. The search depth is 20 years. The main mechanisms of the effect of scratching on increasing endometrial receptivity include decidualization, the development of a local inflammatory reaction, as well as improved synchronization between the uterine mucosa and the transferred embryo by preventing premature maturation of the endometrium. Studies that showed a positive effect of local damage to the uterine mucosa were mainly conducted in patients with repeated implantation failures and with intervention in the luteal phase of the cycle preceding stimulation. At the same time, the work performed in a non-selective population of women and non-standardized by exposure time, in most cases, did not reveal the advantages of endometrial scratching. In this regard, additional qualitative randomized controlled trials with a large sample size and a clear identification of groups of patients for whom this intervention may benefit are required.
- 20 January 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 23,p. 224-230
Open AccessEffectiveness of endometrial scratching in infertility treatment with assisted reproductive technologies
Embryo implantation is a key factor limiting the effectiveness of assisted reproductive technologies, and depends on the quality of the blastocyst and the susceptibility of the endometrium. Various methods of treatment aimed at improving the receptivity of the uterine mucosa, including endometrial scratching, have been proposed. At the same time, the main mechanisms underlying this intervention remain unclear. Moreover, the optimal duration of exposure to the uterine mucosa and the groups of patients in which it can have a positive effect have not been determined. The study aims to investigate the main mechanisms and evaluate the effectiveness of local endometrial damage performed at various times before embryo transfer in the program of assisted reproductive technologies in women with and without a history of implantation failures based on the analysis of scientific literature. Clinical studies, systematic reviews and meta-analyses were studied in PubMed, Embase, Cochrane Library, Web of Science databases, Elsevier, Springer, Wiley publishers, on eLibrary, Research Gate platforms, in open sources of the scientific and educational segment of the Internet. The literature search was conducted by keywords: endometrial scratching, local endometrial damage, implantation failures, endometrial receptivity, assisted reproductive technologies, infertility. The search depth is 20 years. The main mechanisms of the effect of scratching on increasing endometrial receptivity include decidualization, the development of a local inflammatory reaction, as well as improved synchronization between the uterine mucosa and the transferred embryo by preventing premature maturation of the endometrium. Studies that showed a positive effect of local damage to the uterine mucosa were mainly conducted in patients with repeated implantation failures and with intervention in the luteal phase of the cycle preceding stimulation. At the same time, the work performed in a non-selective population of women and non-standardized by exposure time, in most cases, did not reveal the advantages of endometrial scratching. In this regard, additional qualitative randomized controlled trials with a large sample size and a clear identification of groups of patients for whom this intervention may benefit are required.
- Open Access
- 1 January 2023
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 11 (3)
Features of the course of pregnancy in women with menstrual cycle disorders and their correction with didrogesterone at the stage of pregravid preparation
Особенности беременности у женщин с нарушениями менструального цикла в анамнезе и их коррекция дидрогестероном на этапе прегравидарной подготовки
- 1 January 2023
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 11 (3)
Open AccessFeatures of the course of pregnancy in women with menstrual cycle disorders and their correction with didrogesterone at the stage of pregravid preparation
Особенности беременности у женщин с нарушениями менструального цикла в анамнезе и их коррекция дидрогестероном на этапе прегравидарной подготовки